Scientists hunt for clues to drug resistance in advanced breast cancer
NCT ID NCT04653740
First seen Mar 20, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This study looks at 25 women with advanced breast cancer to understand why the drug Palbociclib stops working over time. Researchers collect blood and breath samples before and after the cancer progresses. The goal is to find molecular changes that signal resistance, which could lead to better treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Oscar Lambret
Lille, France, 59020, France
Conditions
Explore the condition pages connected to this study.